Suchergebnisse - "Smith, Christopher G"

PubPharm (77)

61

Somatic Profiling of the Epidermal Growth Factor Receptor Pathway in Tumors from Patients with Advanced Colorectal Cancer Treated with Chemotherapy Cetuximab

enthalten in: Clinical cancer research | 2013

von Smith, C. | Fisher, D. | Claes, B. | +12

62

Exome resequencing identifies potential tumor-suppressor genes that predispose to colorectal cancer

enthalten in: Human mutation | 2013

von Smith, C. | Naven, M. | Harris, R. | +11

63

Exome Resequencing Identifies Potential Tumor‐Suppressor Genes that Predispose to Colorectal Cancer

enthalten in: Human mutation | 2013

von Smith, C. | Naven, M. | Harris, R. | +11

64

Over 100 years of environmental change recorded by foraminifers and sediments in Mobile Bay, Alabama, Gulf of Mexico, USA

enthalten in: Estuarine, coastal and shelf science | 2012

von Osterman, L. | Smith, C.

65

Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk

enthalten in: Nature genetics | 2012

von Dunlop, M. | Dobbins, S. | Farrington, S. | +96

66

Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk

enthalten in: Nature genetics | 2012

von Dunlop, M. | Dobbins, S. | Farrington, S. | +164

CommentIn: Gastroenterology. 2012 Dec;143(6):1684-5. - PMID 23073136

67

An investigation of submarine groundwater-borne nutrient fluxes to the west Florida shelf and recurrent harmful algal blooms

enthalten in: Limnology and oceanography | 2012

von Smith, C. | Swarzenski, P.

68

Erratum: An investigation of submarine groundwater-borne nutrient fluxes to the west Florida shelf and recurrent harmful algal blooms

enthalten in: Limnology and oceanography | 2012

von Smith, C. | Swarzenski, P.

69

Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer : results of the randomised phase 3 MRC COIN trial

enthalten in: Lancet (London, England) | 2011

von Maughan, T. | Adams, R. | Smith, C. | +119

CommentIn: Lancet. 2011 Jun 18;377(9783):2060-2. - PMID 21641637

70

Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

enthalten in: The lancet | 2011

von Maughan, T. | Adams, R. | Smith, C. | +18